Announcement of Fosun Pharmaceutical on increasing its shareholding in Foshan Xinglian Nursing Home Co., Ltd. and related transactions
Fosun Pharmaceutical's announcement on foreign investment and relinquishment of priority subscription rights
Announcement of Resolutions of the 51st Meeting (Interim Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical's announcement on the approval of its holding subsidiary for drug registration
Fosun Pharmaceutical's Announcement on Shareholders' Partial Shares Pledges and Cancellation of Pledges
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Information on the 2023 Annual General Meeting of Shareholders of Fosun Pharmaceutical, the first Class A Shareholders' Meeting in 2024, and the first Class H Shareholders' Meeting in 2024
Notice of Fosun Pharmaceutical on holding the 2023 Annual General Meeting of Shareholders, the First Class A Shareholders' Meeting in 2024, and the First Class H Shareholders' Meeting in 2024
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Fosun Pharmaceutical H Share Announcement
Fosun Pharmaceutical H Share Announcement
Fosun Pharmaceutical's announcement that its holding subsidiary has been approved for a supplementary drug application
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical's announcement on the progress of the licensing agreement for its holding subsidiary
Announcement of Resolutions of the 50th Meeting (Interim Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Announcement of Resolutions of the 4th Meeting (Interim Meeting) of the 9th Board of Supervisors of Fosun Pharmaceutical in 2024
Fosun Pharmaceutical's announcement on the signing of a capital increase and stock expansion agreement by its holding subsidiary
Fosun Pharmaceutical's announcement on amending the “Articles of Association” and its annexes
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
No Data